Aktie A214870 NEWGLAB PHARMA CO.,LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen NewGLAB Pharma CO.,LTD

Aktien

A214870

KR7214870008

A214870

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 09.03.2023 		% 5 Tage % 1. Jan.
1 383 KRW -27,44 % Intraday Chart für NewGLAB Pharma CO.,LTD -.--% -.--%
2023 NewGLAB Pharma CO.,LTD meldet Ergebnis für das erste Quartal bis zum 31. März 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
NewGLAB Pharma CO.,LTD announced that it has received KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors
NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors
NewGLAB Pharma CO.,LTD(KOSDAQ:A214870) dropped from S&P Global BMI Index
NewGLAB Pharma CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023
NewGLAB Pharma CO.,LTD announced that it has received KRW 25 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
NewGLAB CO.,LTD announced that it has received KRW 9.23 billion in funding
NewGLAB CO.,LTD announced that it expects to receive KRW 9.23 billion in funding
NewGLAB CO.,LTD announced that it has received KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
NewGLAB CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
NewGLAB CO.,LTD announced that it has received KRW 18 billion in funding
NewGLAB CO.,LTD announced that it expects to receive KRW 18 billion in funding
NewGLAB CO.,LTD(KOSDAQ:A214870) added to S&P Global BMI Index
NewGLAB CO.,LTD announced that it has received KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
An unknown buyer acquired 3.8% stake in NewGLAB CO.,LTD from Ahrenel International.
NewGLAB CO.,LTD announced that it has received KRW 10.000001088 billion in funding
NewGLAB CO.,LTD announced that it has received KRW 5 billion in funding
HDPRO Co., Ltd. announced that it expects to receive KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
Arenel International Co., Ltd. acquired 13.1% stake in HDPRO Co., Ltd. from NextEye Co., Ltd. for KRW 11 billion.
HDPRO Co., Ltd. announced that it expects to receive KRW 10.000001088 billion in funding
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A214870 Aktie
  4. Nachrichten NewGLAB Pharma CO.,LTD
  5. Andere Sprachen